Drug Profile
Research programme: cancer therapeutics - PHD Biosciences
Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Albert Einstein College of Medicine; PHD Biosciences
- Developer PHD Biosciences
- Class Antineoplastics; Small molecules
- Mechanism of Action Gene expression modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Cancer in USA
- 13 Aug 2016 Early research in Cancer in USA (unspecified route)